Theradiag (France) Analysis
Theradiag SA is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Theradiag stock analysis is to determine its intrinsic value, which is an estimate of what Theradiag SA is worth, separate from its market price. There are two main types of Theradiag's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Theradiag's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Theradiag's stock to identify patterns and trends that may indicate its future price movements.
The Theradiag stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Theradiag is usually not traded on Christmas Day, New Year 's Day, Easter Monday, International Workers ' Day, Victory in Europe Day. Theradiag Stock trading window is adjusted to Europe/Paris timezone.
Theradiag |
Theradiag Stock Analysis Notes
About 23.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.19. Theradiag SA had not issued any dividends in recent years. The entity had 367:350 split on the 26th of July 2016. Theraclion SA develops, manufactures, and markets Echopulse ultrasound medical imaging tool for the non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules to practitioners. The company was founded in 2004 and is based in Malakoff, France. THERACLION operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 22 people. For more info on Theradiag SA please contact the company at 33 1 55 48 90 70 or go to https://www.theraclion.com.Theradiag SA Investment Alerts
| Theradiag SA is not yet fully synchronised with the market data | |
| Theradiag SA has some characteristics of a very speculative penny stock | |
| Theradiag SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 1.48 M. Net Loss for the year was (3.76 M) with loss before overhead, payroll, taxes, and interest of (1.4 M). | |
| Theradiag SA has accumulated about 938.86 K in cash with (3.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 23.0% of the company shares are held by company insiders |
Theradiag Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theradiag's market, we take the total number of its shares issued and multiply it by Theradiag's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Theradiag Outstanding Bonds
Theradiag issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Theradiag SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Theradiag bonds can be classified according to their maturity, which is the date when Theradiag SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Theradiag to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Tools for Theradiag Stock
When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |